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Transcatheter arterial embolization (TAE) is the preferred method of treatment for acute ruptured he-
patocellular carcinoma (HCC). However, after we had performed TAE on a patient with HCC whose tumor
had been ruptured in a motor vehicle accident, he developed tumor lysis syndrome (TLS) on the 2nd day
after the procedure. TLS most commonly occurs in children with cancer and leukemia, but has also been
reported in various types of solid tumors, such as liver carcinoma and breast carcinoma. A few case
reports have been published about patients with HCC receiving transcatheter arterial chemo-
embolization, but there have been few reports about complications after TAE for patients with a ruptured
HCC. We report the case of a patient who received TAE for an HCC which had been ruptured in a motor
vehicle accident to highlight this uncommon and easily overlooked situation.
Copyright © 2014, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
A ruptured hepatocellular carcinoma (HCC) is an acute emer-
gency and surgical intervention for this condition is often associ-
ated with high mortality. Transcatheter arterial embolization (TAE)
is an alternative to surgery for arresting tumor bleeding and helps
to stabilize patients1e5. Tumor lysis syndrome (TLS) is an onco-
logical emergency and a potentially lethal complication in patients
treated for cancer. It most commonly occurs after chemotherapy for
high-grade, rapidly proliferating treatment-sensitive tumors, such
as Burkitt lymphoma and acute lymphocytic leukemia6,7. Without
prompt and proper management, the deterioration caused by TLS
can result in death. Early identiﬁcation of this critical condition
reduces the risk of fatal complications.
We present here the case of a 70-year-old man with a HCC that
was ruptured in a motor vehicle accident. The patient received TAEs of interest to declare.
ber 1, Jianmin Road, Lingya
.-H. Liu).
tric Emergency & Critical Care Mein the emergency department (ED). Extreme electrolyte abnor-
malities and anuria occurred on the 2nd day after the TAE
procedure.
2. Case report
Emergency medical technicians brought a 70-year-old man to
our ED after he had been injured in a motor vehicle accident while
out walking in the morning. He reported severe abdominal pain
and we noted distention of his abdomen in the primary survey
during emergency management. His vital signs were as follows:
body temperature, 36.1C; pulse rate, 74 beats/minute; respiration
rate, 20 breaths/minute; blood pressure, 150/80 mmHg; and Glas-
gow Coma Scale score, 15. A focused assessment with sonography
for trauma revealed an accumulation of ﬂuid overMorrison's pouch
and splenic fossa. We immediately arranged contrast-enhanced
abdominal and pelvic computed tomography scans, which
revealed scattered heterogeneous mass lesions on the bilateral
lobes of the liver andmoderate intraperitoneal ﬂuid collectionwith
contrast medium extravasation over the splenic fossa (Fig. 1). The
patient was a carrier for hepatitis B. The laboratory test results are
shown in Table 1. His hemoglobin level was low and serumdicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Computed tomography scan with contrast showing (A) ruptured solid hepatic
tumor with the hemoperitoneum and (B) contrast extravasation (arrow).
Table 1
Laboratory data.
Variable On admission Day 1 Day 3 Reference range,
adults
White blood cell
count (/mm3)
8000 16,700 4500e11,000
Hemoglobin (g/dL) 8.4 9.1 14.4e16.0
Platelets (103/mL) 342 225 150e400
International
normalized ratio
1.02
Serum lactate
dehydrogenase
(U/L)
228,000 225e135
Serum total
bilirubin (mg/dL)
1.2 0.3e1.2
Blood urea
nitrogen (mg/dL)
33 54 6e20
Blood
creatinine (mg/dL)
2.0 3.5 0.7e1.2
Serum
sodium (mmol/L)
138.6 145.1 136e145
Serum
potassium (mmol/L)
4.2 7.4 3.9 3.5e5.1
Serum
phosphate (mg/dL)
12.9 6.6 2.7e4.5
Serum uric
acid (mg/dL)
15.5 5.2 3.4e7.0
a-Fetoprotein
(ng/mL)
31.56 1.09e8.04
Tumor Lysis Syndrome 101potassium (4.2 mmol/L) was within the reference range. With
respect to renal function, blood urea nitrogen (33 mg/dL), and
blood creatinine (2.0 mg/dL) were moderately elevated. Based on
the laboratory data and imaging ﬁndings, the clinical diagnosis was
a ruptured HCC. We consulted a general surgeon for a second
opinion, but surgery did not seem to be the best choice of treatment
and we therefore performed TAE in the ED1. Oliguria and conscious
disturbance occurred 1 day after the TAEwas completed, with acute
kidney injury shown by elevated blood creatinine levels (3.5 mg/
dL). Initially, we regarded these developments as side-effects of our
contrast media, but the patient's condition did not improve after
ﬂuid resuscitation. In addition, hyperkalemia (7.4 mmol/L), hyper-
phosphatemia (12.9 mg/dL), and hyperuricemia (15.5 mg/dL) were
later noted. Suspecting TLS, we immediately administered urine
alkalization and oral allopurinol combined with hemodialysis. The
patient's renal function stabilized after 2 days of aggressive treat-
ment, during which time his electrolyte levels reached the refer-
ence range for plasma potassium (3.9 mmol/L), phosphate (6.6 mg/
dL), and uric acid (5.2 mg/dL). However, acute pulmonary edema
and dyspnea developed on the 4th day after admission. After we
had explained the patient's condition and the required endotra-
cheal intubation to his family, they refused to allow the procedure
and signed a do-not-resuscitate order. Eventually, the patient died
from respiratory failure.
3. Discussion
HCC is the ﬁfth most common type of cancer8 and the third
leading cause of global cancer deaths. In Taiwan, malignant carci-
noma and liver cancer were the ﬁrst and second most common
causes of death, respectively, in 2010. Encountering a ruptured
hepatic tumor is common in emergency situations; in the Far East,
the rupture rate is as high as 10% and the rupture rate in Hong Kong
is approximately 9.7%1,9e12. If an HCC ruptures, emergency TAE is
effective for hemostasis in hemodynamically unstable patients13.
In a retrospective review of 850 patients who underwent 2300
transcatheter arterial chemoembolization (TACE) or TAE pro-
cedures for hepatic tumors, complications were encountered in
4.4% of all patients14. The most common complication was iatro-
genic dissection of a celiac artery and its branches; the secondmost
common complication was intrahepatic biloma formation15. How-
ever, TLS was rarely considered as a complication of TAE, except in a
number of cases where patients underwent TACE for HCC14,16,17.
TLS was ﬁrst reported in 1929 in patients with chronic leue-
mia18. TLS typically occurs infrequently in patients with solid tu-
mors, but is commonly seen in patients with lung carcinoma, breast
carcinoma19, and hematopoietic disorders (e.g., leukemia and high-
grade lymphoma)20. TLS is characterized as a ruptured membrane
of a cell with rich intracellular contents that spill out into the
vascular space. The release of these components can cause severe
metabolic alterations, including hyperkalemia, hyper-
phosphatemia, hyperuricemia, and hypocalcemia. Hyperkalemia
and hyperphosphatemia directly result from rapid cell lysis. Nucleic
acid purines, which are also released after cell breakdown, are ul-
timately metabolized to uric acid by hepatic xanthine oxidase. This
conversion leads to hyperuricemia. Hypocalcemia results from
acute hyperphosphatemia with the subsequent precipitation of
calcium phosphate. Uric acid nephropathy is the major cause of
acute kidney injury. Another cause of acute kidney injury is acute
nephrocalcinosis from the precipitation of calcium phosphate
crystals21. When TLS develops, the standard treatment is to clear
the high plasma levels of potassium, uric acid, and phosphorus, to
correct acidosis, and to prevent acute renal failure22,23. Further-
more, frequent monitoring of electrolytes, urine pH, and ﬂuid
intake and output are required during the acute phase of TLS.
P.-H. Liu et al.102In this case, the patient sustained a ruptured HCC unexpectedly
after a motor vehicle accident; TAE was therefore suggested and
performed immediately. Nevertheless, TLS developed. We under-
took the necessary emergency management procedures and the
electrolyte abnormalities were corrected. Unfortunately, the pa-
tient died from pulmonary edema and acute respiratory failure.
However, we believe that the early recognition of TLS contributes to
the management of this critical condition.
Albeit rare, TLS can occur after the TAE procedure for a ruptured
HCC in adults. TLS can be treated effectively when detected early17.
If this condition is encountered in the ED, close monitoring of
electrolytes and urine output after TAE is recommended. When TLS
develops, effective treatment must be undertaken immediately,
including adequate hydration, urine alkalization, oral medication
(allopurinol or urate oxidate24), or hemodialysis.References
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